The minimally invasive cardiac surgery market is projected to grow at a 5-10% CAGR over the forecast period. Major factors driving growth include increased prevalence of cardiovascular diseases (CVDs), rising demand for minimally invasive cardiac procedures, growing aging population, patient preference for minimally invasive procedures, technological advancement in minimally invasive cardiac surgery, shift towards outpatient and ambulatory surgery centers (ASCs), and rising awareness about cardiovascular health conditions.
Minimally invasive cardiac surgery (MICS), sometimes referred to as keyhole heart surgery, is a sophisticated technique used to perform heart bypass procedures for treating coronary heart disease. In this approach, the surgeon uses specialized surgical instruments to access the heart through a small incision on the left side of the chest. Unlike traditional open-heart surgery, which requires opening the chest cavity, MICS allows access through the natural spaces between the ribs without the need for cutting. This method is less invasive, resulting in reduced trauma and quicker patient recovery.
Download a free sample report for in-depth market insights
https://meditechinsights.com/minimally-invasive-cardiac-surgery-market/request-sample/
Growing demand for minimally invasive cardiac surgery procedures fuels its demand
Minimally invasive cardiac procedures have revolutionized heart surgery by offering safer and less invasive alternatives to traditional open-heart techniques. The adoption of these methods is rapidly growing, driven by the need to reduce patient trauma, shorten recovery times, and lower healthcare costs. Procedures like cardiac catheterization and percutaneous coronary intervention are increasingly preferred due to their significant benefits over conventional approaches. These techniques utilize specialized cardiology devices, such as catheters, stents, and guidewires, which are witnessing rising demand. Moreover, minimally invasive approaches are widely applied in various cardiac surgeries, including mitral valve repair, coronary artery bypass grafting, and aortic valve replacement, further accelerating market growth.
Shift towards minimally invasive cardiac surgery over traditional heart surgery drives market growth
Minimally invasive cardiac surgery (MICS) has transformed the treatment of various heart conditions, offering a safer and equally effective alternative to traditional open-heart surgery. It provides several significant advantages over conventional methods:
• Smaller Incisions & Less Pain: With minimal incisions on the breastbone, MICS reduces post-operative pain and scarring. This approach also preserves chest function and improves breathing after surgery
• Faster Recovery & Return to Daily Activities: Unlike traditional heart surgeries, MICS allows patients to resume normal activities, such as driving and working, much sooner often immediately after the initial recovery phase
• Minimal Blood Loss & Reduced Need for Transfusion: The use of robotic instruments and small incisions minimizes blood loss during the procedure, significantly lowering the need for transfusions and reducing the risk of blood-borne infections
• Lower Risk of Post-Surgical Infections: Due to the smaller incisions, MICS greatly decreases the likelihood of infections, making it particularly beneficial for diabetic and elderly patients with weaker immune systems
• Minimal Scarring & Faster Healing: With incisions as small as 2-4 inches, scarring is virtually non-existent, leading to quicker wound healing with fewer complications
• Shorter Hospital Stays: One of the greatest advantages of MICS is the reduced recovery period. Patients typically stay in the hospital for about five days, compared to nine days for those undergoing traditional open-heart surgery, enabling a faster return to normal life with less rehabilitative care.
By combining advanced surgical techniques with enhanced patient outcomes, MICS continues to redefine the landscape of modern cardiac surgery.
Competitive Landscape Analysis
The global minimally invasive cardiac surgery market is marked by the presence of established and emerging market players such as Abbott Laboratories; Intuitive Surgical; Stryker Corporation; GE HealthCare; Edwards Lifesciences Corporation; Siemens Healthineers; Terumo Corporation; Johnson & Johnson; Philips Healthcare; Medtronic; Boston Scientific Corporation; Zimmer Biomet; Smith & Nephew; Olympus Corporation; and Micro Interventional Devices (MID); among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and investments.
Unlock key data with a sample report for competitive analysis:
https://meditechinsights.com/minimally-invasive-cardiac-surgery-market/request-sample/
Market Segmentation
This report by Medi-Tech Insights provides the size of the global minimally invasive cardiac surgery market at the regional- and country-level from 2023 to 2030. The report further segments the market based on surgery type, procedure type, and end user.
• Market Size & Forecast (2023-2030), By Surgery Type, USD Million
o Robotic-assisted Surgery
o Thoracoscopy Surgery
• Market Size & Forecast (2023-2030), By Procedure Type, USD Million
o Aortic Valve Repair/Replacement
o Mitral Valve Repair/Replacement
o Surgical Radiofrequency Ablation for Atrial Fibrillation
o Tricuspid Valve Repair or Replacement
o Atrial Septal Defect (ASD)
o Ventricular Assist Device (VAD) Implantation
o Coronary Artery Bypass Grafting (CABG)
o Other Procedures
• Market Size & Forecast (2023-2030), By End User, USD Million
o Hospitals
o Ambulatory Surgical Centers (ASCs)
o Speciality Clinics
o Others
• Market Size & Forecast (2023-2030), By Region, USD Million
o North America
US
Canada
o Europe
UK
Germany
France
Italy
Spain
Rest of Europe
o Asia Pacific
China
India
Japan
Rest of Asia Pacific
o Latin America
o Middle East & Africa
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
[email protected]
Top comments (0)